Short Interest in Ocean Biomedical, Inc. (NASDAQ:OCEAW) Decreases By 22.5%

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the target of a large drop in short interest in the month of July. As of July 31st, there was short interest totalling 21,400 shares, a drop of 22.5% from the July 15th total of 27,600 shares. Based on an average daily volume of 13,500 shares, the days-to-cover ratio is presently 1.6 days.

Ocean Biomedical Price Performance

NASDAQ OCEAW remained flat at $0.04 during trading hours on Friday. The company’s stock had a trading volume of 101 shares, compared to its average volume of 35,214. Ocean Biomedical has a fifty-two week low of $0.02 and a fifty-two week high of $0.70. The company’s 50 day moving average is $0.04 and its 200 day moving average is $0.11.

Ocean Biomedical Company Profile

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.